Oral soft tissue alterations in patients with neurofibromatosis

Springer Science and Business Media LLC - Tập 16 - Trang 551-558 - 2011
Eeva-Mari Jouhilahti1, Vivian Visnapuu1,2, Tero Soukka2, Heikki Aho3, Sirkku Peltonen4, Risto-Pekka Happonen2, Juha Peltonen1,5
1Institute of Biomedicine, Department of Cell Biology and Anatomy, University of Turku, Turku, Finland
2Department of Oral and Maxillofacial Surgery, University of Turku and Turku University Hospital, Turku, Finland
3Department of Pathology, Turku University Hospital, Turku, Finland
4Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland
5Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland

Tóm tắt

Our aim was to characterize the type and frequency of oral soft tissue alterations in neurofibromatosis. A total of 103 patients with neurofibromatosis 1 (NF1) and three patients with neurofibromatosis 2 (NF2) were clinically evaluated for their oral soft tissue alterations. Disturbing growths were removed from nine patients with NF1 and from one patient with NF2. The specimens were analyzed using routine histological methods and with immunohistochemistry using antibodies to S100, type IV collagen, CD34, neurofilament, and neuron-specific tubulin (TUBB3). Alterations including oral tumors, overgrowths of gingival soft tissue, and enlarged papillae of the tongue were discovered in 74% of NF1 patients. The results showed that three tumors clinically classified as plexiform neurofibromas and five out of six discrete mucosal tumors displayed histology and immunohistology consistent with that of neurofibroma. The histology of one palatal lesion resembled that of a scar, and the lesion removed from the patient with NF2 was classified as an amyloid tumor. To conclude, oral soft tissue growths are common findings in NF1, but most lesions do not require treatment and the patients may even not be aware of these alterations. Collagen IV, S100, and CD34 are useful biomarkers in the analysis of NF1-related oral soft tissue tumors. The clinicians should recognize that oral soft tissue alterations are relatively common in NF1. Some of the growths are disturbing, and plexiform neurofibromas may bear a risk of malignant transformation.

Tài liệu tham khảo

Huson SM (2008) The neurofibromatoses: classification, clinical features and genetic counselling. In: Kaufmann D (ed) Neurofibromatoses. Karger, Basel, pp 1–20 Lammert M, Friedman J, Kluwe L, Mautner VF (2005) Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 141:71–74 Bollag G, McCormick F, Clark R (1993) Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity. EMBO J 12:1923–1927 Stumpf D, Alksne J, Annegers J et al (1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578 Evans D (2009) Neurofibromatosis 2 [bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]. Genet Med 11:599–610 Depprich R, Singh DD, Reinecke P, Kübler NR, Handshel J (2009) Solitary submucous neurofibroma of the mandible: review of the literature and report of a rare case. Head Face Med 5:24 do Nascimento G, de Albuquerque Pires Rocha D, Galvão H, de Lisboa Lopes Costa A, de Souza LB (2010) A 38-year review of oral schwannomas and neurofibromas in a Brazilian population: clinical, histopathological and immunohistochemical study. Clin Oral Investig. doi:10.1007/s00784-010-0389-7 Shapiro SD, Abramovitch K, Van Dis ML, Skoczylas LJ, Langlais RP, Young RS, Riccardi VM (1984) Neurofibromatosis: oral and radiographic manifestations. Oral Surg Oral Med Oral Pathol 58:493–498 D'Ambrosio J, Langlais R, Young R (1988) Jaw and skull changes in neurofibromatosis. Oral Surg Oral Med Oral Pathol 66:391–396 Powell CA, Stanley CM, Bannister S, McDonnell HT, Moritz AJ, Deas DE (2006) Palatal neurofibroma associated with localized periodontitis. J Periodontol 77:310–315 Lassmann H, Jurecka W, Lassmann G, Gebhart W, Matras H, Watzek G (1977) Different types of benign nerve sheath tumors. Light microscopy, electron microscopy and autoradiography. Virchows Arch A Pathol Anat Histol 375:197–210 Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J (1988) Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 59:760–771 Pummi K, Aho H, Laato M, Peltonen J, Peltonen S (2006) Tight junction proteins and perineurial cells in neurofibromas. J Histochem Cytochem 54:53–61 Riccardi V (2007) The genetic predisposition to and histogenesis of neurofibromas and neurofibrosarcoma in neurofibromatosis type 1. Neurosurg Focus 22:E3 Hassell D, Bancroft L, Kransdorf M, Peterson JJ, Berquist TH, Murphey MD, Fanburg-Smith JC (2008) Imaging appearance of diffuse neurofibroma. AJR Am J Roentgenol 190:582–588 Majoie C, Hulsmans F, Castelijns J, Sie LH, Walter A, Valk J, Albrecht KW (1999) Primary nerve-sheath tumours of the trigeminal nerve: clinical and MRI findings. Neuroradiology 41:100–108 Visnapuu V, Peltonen S, Ellilä T, Kerosuo E, Väänänen K, Happonen RP, Peltonen J (2007) Periapical cemental dysplasia is common in women with NF1. Eur J Med Genet 50:274–280 Visnapuu V, Pienihäkkinen K, Peltonen S, Happonen RP, Peltonen J (2011) Neurofibromatosis 1 and dental caries. Clin Oral Investig 15:119–121 Jouhilahti E, Peltonen S, Peltonen J (2008) Class III beta-tubulin is a component of the mitotic spindle in multiple cell types. J Histochem Cytochem 56:1113–1119 Chaubal A, Paetau A, Zoltick P, Miettinen M (1994) CD34 immunoreactivity in nervous system tumors. Acta Neuropathol 88:454–458 Jaakkola S, Muona P, James W, Hannuksela M, Karvonen J, Peltonen J, Uitto J (1990) Segmental neurofibromatosis: immunocytochemical analysis of cutaneous lesions. J Am Acad Dermatol 22:617–621 Baden E, Jones J, Khedekar R, Burns WA (1984) Neurofibromatosis of the tongue: a light and electronmicroscopic study with review of the literature from 1849 to 1981. J Oral Med 39:157–164 Friedrich R, Giese M, Schmelzle R, Mautner VF, Scheuer HA (2003) Jaw malformations plus displacement and numerical aberrations of teeth in neurofibromatosis type 1: a descriptive analysis of 48 patients based on panoramic radiographs and oral findings. J Craniomaxillofac Surg 31:1–9 Cunha K, Barboza E, Dias E, Oliveira FM (2004) Neurofibromatosis type I with periodontal manifestation. A case report and literature review. Br Dent J 196:457–460 García de Marcos J, Dean Ferrer A, Alamillos Granados F et al (2007) Gingival neurofibroma in a neurofibromatosis type 1 patient. Med Oral Patol Oral Cir Bucal 12:E287–E291 Alivuotila L, Hakokari J, Visnapuu V et al (2010) Speech characteristics in neurofibromatosis type 1. Am J Med Genet A 152A:42–51 Rautava J, Luukkaa M, Heikinheimo K, Alin J, Grenman R, Happonen RP (2007) Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival. Oral Oncol 43:911–919